Loading clinical trials...
Loading clinical trials...
A Phase II Study of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
Conditions
Interventions
Hippocampal-avoidance proton therapy
Locations
2
United States
Mayo Clinic
Rochester, Minnesota, United States
St. Jude Children's Research Hospital
Memphis, Tennessee, United States
Start Date
August 28, 2019
Primary Completion Date
July 1, 2027
Completion Date
July 1, 2028
Last Updated
April 24, 2026
NCT03206060
NCT05636618
NCT07243470
NCT05099003
NCT03340506
NCT02800486
Lead Sponsor
St. Jude Children's Research Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions